Microdosing

Microdosing LSD has no clear benefit for ADHD, according to a new placebo-controlled clinical trial published in JAMA Psychiatry.

Researchers observed a 1250% increase in microdosing-related Google searches from 2015 to 2023, coinciding with the loosening of cannabis and psychedelic regulations, with over three million searches in 2023 alone.

Microdosing LSD leads to participants sleeping 24 minutes longer and going to bed 25 minutes earlier, with an 8-minute increase in REM sleep, according to a recent study published in Translational Psychiatry.

A preliminary study published in European Psychiatry found that microdosing psychedelics like LSD and psilocybin may reduce ADHD symptoms and enhance emotional regulation in adults.

LSD increases neural complexity and reduces certain brain wave frequencies, which correlates with feelings of elation, according to new research.

A study on rats suggests that microdosing psilocybin could reduce stress-induced anhedonia and compulsive behaviors without causing anxiety or schizophrenia-like symptoms. This research offers insights into psilocybin's potential as a therapy for mental health disorders, though further human studies are...

Adults with ADHD who practiced microdosing psychedelics reported increased mindfulness after four weeks, according to a study in Frontiers in Psychiatry. The research highlights the need for controlled studies to validate these findings

In recent years, the trend of microdosing psychedelics has gained popularity, with enthusiasts touting a wide range of potential benefits, from enhanced creativity to improved mood and focus. However, a recent scientific review published in the Journal of Psychopharmacology has...

The practice of "microdosing" appears to result in a decrease in emotional diversity, according to new research published in the Journal of Psychedelic Studies.

A single, low dose of  lysergic acid diethylamide (LSD) can increase reward-related brain activity, according to new research published in Neuropsychopharmacology. The study indicates that the psychedelic drug alters neuropsychological processes that tend to be blunted in patients with depression.

Anecdotal evidence suggests that microdosing with psilocybin mushrooms offers mental health benefits. But a recent experimental study suggests that these purported benefits may be driven by users’ expectations. Findings from the placebo-controlled experiment were published in the journal Translational Psychiatry.

Psilocybin, the active compound in “magic mushrooms,” has been shown to be a promising treatment for various mental health issues. New research published in Scientific Reports found that people who microdose psychedelics displayed greater improvements in mental health and mood...

A new randomized controlled study of LSD microdosing has failed to find evidence that the psychedelic practice results in improvements to mood or cognition.

Zebrafish might seem an odd choice in studying human health, but they share 70 per cent of their genes with us and are a popular nonhuman organism used by scientists to study biological processes. They are also incredibly social, making...